Yamagata, Shigehito <br/><br/>
Dihydropyrimidine dehydrogenase inhibitory fluoropyrimidine S-1 may be effective against peritoneal dissemination in gastric cancer.  [electronic resource] 

 -  Oncology reports  Nov 2004 
 - 973-8 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1021-335X 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Oral<br/>Animals<br/>Antimetabolites, Antineoplastic--administration & dosage<br/>Ascites--metabolism<br/>Dihydrouracil Dehydrogenase (NADP)--antagonists & inhibitors<br/>Drug Combinations<br/>Female<br/>Fluorouracil--metabolism<br/>Injections, Intraperitoneal<br/>Mice<br/>Mice, Inbred BALB C<br/>Mice, Nude<br/>Oxonic Acid--administration & dosage<br/>Peritoneal Neoplasms--drug therapy<br/>Pyridines--administration & dosage<br/>Stomach Neoplasms--drug therapy<br/>Survival Rate<br/>Tegafur--administration & dosage<br/>Tumor Cells, Cultured